Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy

BACKGROUND: Whether adjuvant chemotherapy is beneficial for rectal cancer patients who respond well to neoadjuvant chemoradiotherapy (NCRT) and undergo radical resection is controversial. This study aimed to assess the effect of adjuvant chemotherapy on the oncological outcomes of ypT0-2N0 rectal ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transl Med
Hlavní autoři: Zhang, Hang, Huang, Ya, Sun, Ge, Zheng, Kuo, Lou, Zheng, Gao, Xian-Hua, Hao, Li-Qiang, Liu, Lian-Jie, Meng, Rong-Gui, Zhang, Wei
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7333111/
https://ncbi.nlm.nih.gov/pubmed/32647668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1278
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky